Manal M. Alanazi

New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis

Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi et al. · Bioorganic Chemistry · 2021 · 104 citations

Medicinal Chemistry, New Quinoxaline Derivatives, Medicine +8

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with <i>in silico</i> docking, ADMET, toxicity, and DFT studies

Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif et al. · RSC Advances · 2021 · 67 citations · Full text

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-<i>a</i>:3',4'-<i>c</i>]quinoxaline derivatives as anticancer agents and apoptosis inducers

Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 60 citations · Full text

Theoretical study of the antioxidant mechanism and structure-activity relationships of 1,3,4-oxadiazol-2-ylthieno[2,3-d]pyrimidin-4-amine derivatives: a computational approach

Ahmed H. Bakheit, Tanveer A. Wani, Abdulrahman A. Al‐Majed et al. · Frontiers in Chemistry · 2024 · 17 citations · Full text

Design, synthesis and biological evaluation of pyrazolo[3,4- <i>b</i> ]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity

Mahmoud S Elkotamy, Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani et al. · Journal of Biomolecular Structure and Dynamics · 2025 · 11 citations